Genocea Biosciences Inc GNCA:OTCPK

RT Quote | Exchange | USD
Last | 09/23/22 EDT
0.0152quote price arrow up+0.0006 (+3.84%)
Volume
1,146,893
52 week range
0.01 - 2.15
Loading...
  • Open0.0142
  • Day High0.0175
  • Day Low0.0115
  • Prev Close0.0152
  • 52 Week High2.15
  • 52 Week High Date09/30/21
  • 52 Week Low0.01
  • 52 Week Low Date09/21/22

Key Stats

  • Market Cap890,000.00
  • Shares Out58.78M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta1.82
  • YTD % Change-98.69

KEY STATS

  • Open0.0142
  • Day High0.0175
  • Day Low0.0115
  • Prev Close0.0152
  • 52 Week High2.15
  • 52 Week High Date09/30/21
  • 52 Week Low0.01
  • 52 Week Low Date09/21/22
  • Market Cap890,000.00
  • Shares Out58.78M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta1.82
  • YTD % Change-98.69

RATIOS/PROFITABILITY

  • EPS (TTM)-0.52
  • P/E (TTM)-0.03
  • Fwd P/E (NTM)-0.02
  • EBITDA (TTM)-53.868M
  • ROE (TTM)-525.78%
  • Revenue (TTM)1.91M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-1,946.15%
  • Debt To Equity (MRQ)61.74%

EVENTS

  • Earnings Date10/26/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Genocea Biosciences Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Genocea Biosciences, Inc. is a biopharmaceutical company. The Company is focused on discovering and developing cancer immunotherapies using its Antigen Lead Acquisition System (ATLAS) platform. The ATLAS platform can profile each patient's CD4+ and CD8+ T cell immune responses to every potential target or antigen identified by sequencing of that patient's tumor. Its product candidates include GEN-011 and GEN-009. GEN-011 is an investigational solid tumor cell therapy...
Kenneth Bate
Independent Chairman of the Board
William Clark
President, Chief Executive Officer, Director
Diantha Duvall
Chief Financial Officer
Raymond Stapleton Jr., Ph.D.
Executive Vice President - Pharmaceutical Sciences and Manufacturing
Address
100 Acorn Park Drive
Cambridge, MA
02140
United States

Top Peers

SYMBOLLASTCHG%CHG
BNTC
Benitec Biopharma Inc
0.3205-0.0046-1.4149%
TLOG
TetraLogic Pharmaceuticals Corp
0.0002UNCHUNCH
FWBI
First Wave BioPharma Inc
1.37+0.07+5.38%
AMBS
Amarantus Bioscience Holdings Inc
0.004UNCHUNCH
PALI
Palisade Bio Inc
0.1141-0.0094-7.6113%
KLDO
Kaleido Biosciences Inc
0.0012+0.0001+9.09%